Skip to main content
Premium Trial:

Request an Annual Quote

Microbix Taps Thomas Scientific as US Distribution Partner for Dx Quality Assessment Products

NEW YORK — Microbix Biosystems said on Wednesday that it has signed a US distribution deal for its quality assessment products with Thomas Scientific.

Under the terms of the deal, Swedesboro, New Jersey-based Thomas Scientific will provide customer service, sales and marketing, distribution, and related logistical support for Microbix's quality assessment products, or QAPs.

Additional terms were not disclosed.

Mississauga, Ontario-based Microbix offers more than 70 quality assessment products to support the accuracy of infectious disease diagnostic tests, including ones for molecular assays that detect SARS-CoV-2 variants of concern.

Thomas Scientific is Microbix's second US distribution partner. In early 2020, Microbix inked a similar deal with Alpha-Tec Systems.

"We're aiming for the US market to achieve 10 [times] the QAPs revenue we do in Canada, and now with [Thomas Scientific's] 175 active sales professionals generating leads and five molecular specialists helping close them, our targets should be achieved," Phil Casselli, senior VP of sales and business development at Microbix, said in a statement.

Last month, Microbix signed on SDT Molecular to distribute its products in Hong Kong, Indonesia, Malaysia, and Singapore.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.